Veredus Laboratories, a Singapore-based subsidiary of STMicroelectronics, has introduced a multiplexed molecular diagnostic platform for identifying the specific mycobacterium causing the infection and drug resistance. The VereMTB ...
Tags: Veredus, diagnostic platform, mycobacterium, drug resistance
Iverson Genetic Diagnostics has signed an agreement with Johns Hopkins University School of Medicine to license a molecular diagnostics test which determines cardiovascular risk in men and women and infertility risk in women. Under the ...
Tags: Iverson, agreement, molecular diagnostics test, heart disease
Seegene has developed a new real-time multiplex quantification molecular diagnostic testing technology. The new technology is designed for the simultaneous detection and quantification of up to 20 analytes on an existing 4-channel ...
With the launch of Simatic S7-1500, the Siemens Industry Automation division is introducing a controller family of the next generation for medium to high-end machine and plant automation. The new generation of controllers is characterized ...
Tags: controller, cable, medium to high-end machine and plant automation
Ossid, a division of Pro Mach is all set to introduce its Integrity horizontal form-fill-seal machine, which has been designed to meet United States Department of Agriculture (USDA) meat, poultry, dairy, and 3-A Sanitary Standards. ...
Tags: form-fill-seal machine, remote diagnostics, modular design
Critical Diagnostics has announced two new distribution partners for cardiac biomarker test, the Presage ST2 assay, in the Asia Pacific region. The company has selected Chennai Medipoint as distributor in India, Nepal, Bangladesh, Sri ...
Tags: Critical Diagnostics, cardiac biomarker test, presage ST2 assay, ST2
Quest Diagnostics has received FDA 510(k) clearance for its Simplexa C difficile Universal Direct Test on the 3M Integrated Cycler. The test, which uses a proprietary chemistry that eliminates the need for nucleic-acid extraction, is ...
Tags: Quest Diagnostics, 3M integrated cycler, Simplexa tests
True Diagnostics has gained CE-mark approval to distribute its TrueDX platform and quantitative thyroid-stimulating hormone (TSH) test in Europe. The TrueDX platform helps physicians to determine whether a patient suffers from a ...
Tags: TrueDX platform, thyroid-stimulating hormone test, TSH test
Cardiovascular diagnostics developer BG Medicine has filed a 510(k) Premarket Notification with the US Food and Drug Administration (FDA) for regulatory clearance for the ARCHITECT Galectin-3 assay. Used with Abbott's fully automated ...
VelaDx has signed a license and supply agreement with Life Technologies to develop new sequencing-based in vitro diagnostic (IVD) tests on the Ion Personal Genome Machine (PGM) sequencer. Under the agreement, VelaDx will seek approvals ...
Tags: sequencing-based in vitro diagnostic tests, IVD tests, Ion PGM sequencer
Roche has gained FDA approval for the new HIV viral load test, the COBAS TaqMan HIV-1 Test, v2.0, and will launch the product in the US, later in 2012. The COBAS TaqMan HIV-1 Test, v2.0, targets two highly conserved regions of the HIV-1 ...
Dako, a manufacturer of cancer diagnostics solutions, has received approval from the US Food and Drug Administration to market HercepTest and Her2 Fish pharmDx kit as co diagnostics for pertuzumab (Perjeta), a Genentech cancer drug. ...
Tags: Dako, HER2-positive metastatic breast cance, HER2 FISH pharmDx Kit
BG Medicine has announced the availability of galectin-3 testing services through Atherotech Diagnostics Lab. Atherotech leverages BGM Galectin-3 test to offer galectin-3 testing. The BGM Galectin-3 test was cleared as an aid in ...
Global manufacturer of medical diagnostic systems Sekisui Diagnostics has opted technologies developed by US-based EMC for setting up a new data center infrastructure. As part of its spinoff from Genzyme, Sekisui preferred EMC VNX ...
Tags: data center infrastructure, Sekisui Diagnostics, EMC technologies
Bexsero, Novartis' Meningococcal Group B Vaccine, has won a positive opinion from European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP). The CHMP opinion indicates the use of the broad coverage vaccine in ...